Search results
Inhibikase Therapeutics First Quarter 2024 Earnings: US$0.73 loss per share (vs US$0.98 loss in 1Q...
Simply Wall St. via Yahoo Finance· 17 hours agoInhibikase Therapeutics (NASDAQ:IKT) First Quarter 2024 Results Key Financial Results Net loss:...
Menang Corporation (M) Berhad Third Quarter 2024 Earnings: EPS: RM0.014 (vs RM0.006 in 3Q 2023)
Simply Wall St. via Yahoo Finance· 6 hours agoKLSE:MENANG Earnings and Revenue History May 21st 2024 Menang Corporation...week ago. Risk Analysis...
Centerra Gold First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 17 hours agoCenterra Gold (TSE:CG) First Quarter 2024 Results Key Financial Results Revenue...0.31 (up from...
TJX (TJX) Q1 Earnings Report Preview: What To Look For
StockStory via Yahoo Finance· 21 hours agoTJX a buy or sell going into earnings? Read our full analysis here, it's free. This quarter,...
Edible Garden First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 17 hours agoEdible Garden (NASDAQ:EDBL) First Quarter 2024 Results Key Financial Results Revenue: US$3.13m (up...
3 Stocks to Watch Closely for Superb Earnings Acceleration
Zacks· 2 days agoInsistent earnings growth enthralls everyone, from the top brass to research analysts. Studies have...
Stocks Close Higher As Investors Await Nvidia Earnings
Investor's Business Daily· 8 hours agoPalo Alto Networks stock pared larger losses to 3.7% in heavy volume on the stock market today after...
Analysts reboot Palo Alto Networks stock price target after earnings
TheStreet via Yahoo Finance· 5 hours agoNikesh...I'm delighted to report, despite the concerns around our platformization approach after our...
Theravance Biopharma First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 18 hours agoNasdaqGM:TBPH Earnings and Revenue Growth May 21st 2024 Theravance Biopharma... ahead, revenue is...
Q1 2024 Biomx Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 19 minutes agoThe increase was primarily due to expenses related to the merger with APT and the concurrent private placement. Net loss for the first quarter of 2024 was $17.3< ...
